Ataxia-telangiectasia mutated expression is associated with tobacco smoke exposure in esophageal cancer tissues and benzo[a]pyrene diol epoxide in cell lines

International Journal of Cancer

Volumn 120, Issue 1, 2007, Pages 91-95

  Jiang, Yan ^a   Liang, Zheng D ^b   Wu, Tsung T ^b   Cao, Liya ^a   Zhang, Hongfu ^a   Xu, Xiao Chun ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

ATM; Biomarker; BPDE; Esophageal cancer; Tobacco smoke

Indexed keywords

DIHYDROXYBENZO[A]PYRENE OXIDE; MESSENGER RNA; TOBACCO SMOKE; TUMOR MARKER;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ATM GENE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; POLLUTION; PRECANCER; PRIORITY JOURNAL; SMOKING; TUMOR DIFFERENTIATION;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; BLOTTING, WESTERN; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; PRECANCEROUS CONDITIONS; PROTEIN-SERINE-THREONINE KINASES; RNA, MESSENGER; SMOKING; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 33845404197     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22121     Document Type: Article

References (30)

1. Richter JE, Esophagus. In: Brandt LJ, ed. Clinical practice of gastroenterology, vol. 1. Philadelphia: Churchill Livingstone, 1999.1-150.
2. Mandard AM, Hainaut P, Holtstein M. Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat Res 2000;462:335-42.
3. Enzinger PC, Mayer RJ, Esophageal cancer. N Engl J Med 2003;349:2241-52.
4. Montesano R, Hollstein M, Hainaut P. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer 1996;69:225-35.
5. Yu MC, Garabrant DH, Peters JM, Mack TM, Tobacco, alcohol, diet, occupation, and carcinoma of the esophagus. Cancer Res 1988;48:3843-8.
6. Gao YT, Zheng W, Gao RN, Jin F. Tobacco smoking and its effect on health in China. IARC Sci Publ 1991;105:62-7.
7. Cheng KK, Day NE, Davies TW. Oesophageal cancer mortality in Europe: paradoxical time trend in relation to smoking and drinking. Br J Cancer 1992;65:613-7.
8. Redmond DE, Jr. Tobacco and cancer: the first clinical report, 1761. N Engl J Med 1970;282:18-23.
9. US Surgeon General. The health consequences of smoking-cancer. DHHS Publ No (OHS) 82-50179, Washington, DC, 1982.
10. International Agency for Research on Cancer. Tobacco smoking. IARC Monogr 38, Lyon, France: IARC press, 1986.
11. Hoffmann D, Hecht SS. Advances in tobacco carcinogenesis. In: Cooper CS, Grover PE, eds. Chemical carcinogenesis and mutagenesis. I. Handbook of experimental pharmacology, vol. 94. Berlin: Springer-Verlag, 1990, 63-102.
12. Osborne MR, Crosby NT, eds. Benzopyrenes. Cambridge: Cambridge University Press, 1987.
13. Denissenko MF, Pao A, Tang M, Pfeifer GP. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 1996;274:430-2.
14. Song S, Xu X-C. Effect of benzo[a]pyrene diol epoxide on expression of retinoic acid receptors in esophageal cells. Biochem Biophys Res Commun 2001;281:872-7.
15. Song S, Lippman SM, Zou Y, Ye X, Ajani JA, Xu X-C. Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-β2 expression. Oncogene 2005;24: 8268-76.
16. Liang Z, Lippman SM, Kawabe A, Shimada Y, Xu XC. Identification of benzo(a)pyrene diol epoxide-binding DNA fragments using DNA immunoprecipitation technique. Cancer Res 2003;63:1470-4.
17. Xu XC, Liu X, Tahara E, Lippman SM, Lotan R. Expression and up-regulation of retinoic acid receptor-β is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines. Cancer Res 1999;59:2477-83.
18. Mass MJ, Jeffers AJ, Ross JA, Nelson G, Galati AJ, Stoner GD, Nesnow S. Ki-ras oncogene mutations in tumors and DNA adducts formed by benz[j]aceanthrylene and benzo[a]pyrene in the lungs of strain A/J mice. Mol Carcinog 1993;8:186-92.
19. Huang C, Huang Y, Li J, Hu W, Aziz R, Tang MS, Sun N, Cassady J, Stoner GD. Inhibition of benzo(a) pyrene diol-epoxide-induced transactivation of activated protein 1 and nuclear factor κB by black raspberry extracts. Cancer Res 2002;62:6857-63.
20. Liu Z, Muehlbauer KR, Schmeiser HH, Hergenhahn M, Belharazem D, Hollstein MC. p53 mutations in benzo(a)pyrene-exposed human p53 knock-in murine fibroblasts correlate with p53 mutations in human lung tumors. Cancer Res 2005;65:2583-7.
21. Qiu H, Zhang W, El-Naggar AK, Lippman SM, Lin P, Lotan R, Xu XC. Loss of retinoic acid receptor-β expression is an early event during esophageal carcinogenesis. Am J Pathol 1999;155:1519-23.
22. Shiloh Y. ATM (ataxia telangiectasia mutated): expanding roles in the DNA damage response and cellular homeostasis. Biochem Soc Trans 2001;29:661-6.
23. Lavin MF, Birrell G, Chen P, Kozlov S, Scott S, Gueven N. ATM signaling and genomic stability in response to DNA damage. Mutat Res 2005;569:123,4.
24. Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 2001;27:247-54.
25. Peretz S, Jensen R, Baserga R, Glazer PM. ATM-dependent expression of the insulin-like growth factor-I receptor in a pathway regulating radiation response. Proc Natl Acad Sci USA 2001;98: 1676-81.
26. Angele S, Falconer A, Foster CS, Taniere P, Eeles RA, Hall J. ATM protein overexpression in prostate tumors: possible role in telomere maintenance. Am J Clin Pathol 2004;121:231-6.
27. Ding S, Chamberlain M, McLaren A, Goh L, Duncan I, Wolf CR. Cross-talk between signalling pathways and the multidrug resistant protein MDR-1. Br J Cancer 2001;85:1175-84.
28. Albrecht B, Hausmann M, Zitzelsberger H, Stein H, Siewert JR, Hopt U, Langer R, Hofler H, Werner M, Walch A. Array-based comparative genomic hybridization for the detection of DNA sequence copy number changes in Barrett's adenocarcinoma. J Pathol 2004;203:780-8.
29. Guha C, Guha U, Tribius S, Alfieri A, Casper D, Chakravarty P, Mellado W, Pandita TK, Vikram B. Antisense ATM gene therapy: a strategy to increase the radiosensitivity of human tumors. Gene Ther 2000;7:852-8.
30. Shen KC, Heng H, Wang Y, Lu S, Liu G, Deng CX, Brooks SC, Wang YA. ATM and p21 cooperate to suppress aneuploidy and subsequent tumor development. Cancer Res 2005;65:8747-53.